R&T News: Coffee; Interferon-Free Combo; Telaprevir; Genetic Testing

[Guest guest]

This Research & Treatment News update gives you highlights from the latest articles posted to Hepatitis-Central.com for patients and their families, caregivers and health professionals. With new information being published regularly, we want you to have the latest news on treatments, clinical trials, social issues and important breakthroughs.

Is Coffee a Wise Adjunct to Hepatitis C Therapy?

In the debate over coffee’s effect on health, coffee lovers who are undergoing treatment for Hepatitis C have just scored a victory. Read more.

Interferon-Free Combo Squashes the Hepatitis C Virus

New data about a combination of Pharmasset’s developmental drugs claim a 94 percent success rate for Hepatitis C in just two weeks. Not only were these drugs highly effective in a short period of time, but they also did so without interferon. Read more.

Telaprevir Shows Promise in Those Co-Infected with Hepatitis C and HIV

Preliminary results from a Phase 2 trial demonstrated that 70 percent of people co-infected with Hepatitis C and HIV had undetectable levels of Hepatitis C after just four weeks of treatment with telaprevir. Read more.

Genetic Testing for Hep C Therapy Routine at Scripps Health

A California based health system will be one of the first to routinely order IL28B genotyping on all patients with Hepatitis C who are potential candidates for antiviral therapy. Read more.

More Support for Genetic Testing of Hepatitis C Patients

A large retrospective study further confirms that the IL28B genotype predicts both early and sustained responses to interferon-based Hepatitis C treatment. Read more.

Your Opinion Wanted:

Have you or someone you know ever participated in a clinical trial?

YesNo

VISIT the Clinical Trial poll today.Are you interested in finding a clinical trial near you? If so, check with your medical provider, support groups and the Internet. Local medical centers and/or medical universities may also conduct clinical trials.Or, visit www.clinicaltrials.gov and type “Hepatitis C†into the search field on the main page. A listing of all current clinical trials testing medications for Hepatitis C will appear. To find out more information about any given trial, click on the title for expanded details, as well as the criteria for participating.

We asked, you responded:

Experts now know that for anyone with chronic Hepatitis C, glutathione deficiency is an important factor contributing to further liver damage. How do you or someone you know boost glutathione?

15%: Exercise regularly5%: Eat sulfur-rich vegetables like broccoli, cauliflower, garlic and onions3%: Eat selenium-rich foods like oats, brazil nuts, tuna and black beans10%: Supplement with milk thistle, alpha R-lipoic acid or N-acetyl-L-cysteine64%: All of the Above2%: None of the Above

To learn even more about Hepatitis C and what you can do about it, visit Hepatitis-Central.com. You'll find more than 2,750 pages of in-depth information for HCV patients and their families, caregivers and health professionals. If you would like to review an article you saw in one of these recent Research & Treatment News updates, or would like to search through any of the archived, in-depth news and commentary pages, you ought to browse Hepatitis C Information Central at Hepatitis-Central.com.

Note: LiverSupport Health News, our “sister†e-newsletter, gives you valuable lifestyle suggestions and news-you-can-use from our LiverSupport.com editors. Just click here to sign up for LiverSupport Health News, and learn even more about supporting liver health for you and your family.

Yours in health,Editors@...www.Hepatitis-Central.com1-800-364-5722

Do you have a friend or relative who would find the information in this Research & Treatment News update useful? You can forward this email to them, so they can begin reading all the latest hepatitis research and liver support news. If you're not a current subscriber, click here to sign up today. To be sure you keep receiving this newsletter, click here to confirm your subscription. To guarantee that future mailings from us are not blocked, please add Editors@... to your address book.

As a subscriber, you will be kept up-to-date about emerging information regarding news and research advances. We value your privacy. We will not rent your e-mail to anyone. Review our Privacy Policy.

Hepatitis-Central.com2331 State Route 17KMontgomery, NY 125491-800-364-5722